B. Bartosch

发表

Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

D. Lavillette, A. Tarr, C. Voisset, 2005, Hepatology.

Characterization of Lassa virus cell entry and neutralization with Lassa pseudoparticles

N. Tordo, B. Bartosch, F. Cosset, 2009 .

Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles

N. Tordo, B. Bartosch, F. Cosset, 2009, Journal of Virology.

Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1

B. Bartosch, S. Kochetkov, O. Smirnova, 2016, Oxidative medicine and cellular longevity.

Hepatitis C virus-induced hepatocarcinogenesis.

F. Zoulim, B. Bartosch, H. Blum, 2009, Journal of hepatology.

Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis

B. Bartosch, S. Kochetkov, O. Ivanova, 2016, Oncotarget.

Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes*

F. Penin, D. Lavillette, B. Bartosch, 2006, Journal of Biological Chemistry.

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis

B. Bartosch, A. Ivanov, O. Khomich, 2019, Cells.

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

P. Schürmann, B. Bartosch, Arvind H. Patel, 2007, Proceedings of the National Academy of Sciences.

Cultivation of Cells in a Physiological Plasmax Medium Increases Mitochondrial Respiratory Capacity and Reduces Replication Levels of RNA Viruses

B. Bartosch, S. Kochetkov, O. Smirnova, 2021, Antioxidants.

Heparanase is upregulated by HCV and favors its replication.

F. Zoulim, B. Bartosch, E. Pécheur, 2022, Journal of hepatology.

HCV and Oxidative Stress in the Liver

B. Bartosch, S. Kochetkov, O. Smirnova, 2013, Viruses.

Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion

F. Penin, L. Riva, B. Bartosch, 2015, Journal of Virology.

Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus

F. Zoulim, S. Clément, B. Bartosch, 2016, PLoS biology.

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

D. Lavillette, B. Bartosch, F. Cosset, 2009, Journal of Virology.

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

S. Emerson, R. Purcell, J. Bukh, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads.

F. Penin, D. Lavillette, B. Bartosch, 2010, The Journal of general virology.

Determinants of High Titer in Recombinant Porcine Endogenous Retroviruses

B. Bartosch, Y. Takeuchi, J. Stoye, 2004, Journal of Virology.

Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology

B. Bartosch, S. Kochetkov, O. Smirnova, 2018, International journal of molecular sciences.

Hepatitis C virus alters metabolism of biogenic polyamines by affecting expression of key enzymes of their metabolism.

B. Bartosch, S. Kochetkov, O. Smirnova, 2017, Biochemical and biophysical research communications.

Oxidative Stress in Infection and Consequent Disease

B. Bartosch, A. Ivanov, M. Isaguliants, 2017, Oxidative medicine and cellular longevity.

Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1

B. Bartosch, S. Kochetkov, O. Smirnova, 2016, Oxidative medicine and cellular longevity.

HCV Core Protein Uses Multiple Mechanisms to Induce Oxidative Stress in Human Hepatoma Huh7 Cells

A. Makarov, B. Bartosch, I. Petrushanko, 2015, Viruses.

Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicity

B. Bartosch, F. Cosset, J. Heeney, 2007, Hepatology.

Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin

B. Bartosch, M. Giovannini, P. Herrlich, 2020, International journal of cancer.

The Mouse IAPE Endogenous Retrovirus Can Infect Cells through Any of the Five GPI-Anchored EphrinA Proteins

B. Bartosch, F. Cosset, T. Heidmann, 2011, PLoS pathogens.

Regulation of Mitochondria-Associated Membranes (MAMs) by NO/sGC/PKG Participates in the Control of Hepatic Insulin Response

B. Bartosch, B. Morio, J. Rieusset, 2019, Cells.

Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein.

B. Bartosch, F. Cosset, T. Heo, 2006, Virus research.

Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer.

B. Bartosch, J. Dubuisson, F. Cosset, 2005, The Journal of general virology.

Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance

F. Zoulim, B. Bartosch, H. Vidal, 2016, Diabetologia.

p21WAF1 is dynamically associated with JNK in human T-lymphocytes during cell cycle progression.

B. Bartosch, J. Blank, Rajnikant Patel, 1998, Journal of cell science.

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins.

M. Kieny, B. Bartosch, G. Paranhos-Baccala, 2004, Vaccine.

CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.

F. Zoulim, B. Bartosch, J. Molle, 2017, The Journal of general virology.

Hepatitis C virus infection propagates through interactions between Syndecan‐1 and CD81 and impacts the hepatocyte glycocalyx

F. Zoulim, B. Bartosch, E. Pécheur, 2017, Cellular microbiology.

Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein

F. Negro, S. Clément, B. Bartosch, 2016, PloS one.

Hepatic inflammation elicits production of proinflammatory netrin‐1 through exclusive activation of translation

F. Zoulim, B. Bartosch, P. Mehlen, 2022, Hepatology.

Hepatitis C Virus-Induced Mitochondrial Dysfunctions

B. Bartosch, P. Lévy, C. Brault, 2013, Viruses.

Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity

M. Odenthal, F. Zoulim, B. Bartosch, 2014, Gut.

Retraction statement: Disruption of cyclophilin D–mediated calcium transfer from the endoplasmic reticulum to mitochondria contributes to hepatic endoplasmic reticulum stress and insulin resistance

F. Zoulim, B. Bartosch, H. Vidal, 2013, Hepatology.

Hepatitis B and C Viruses and Hepatocellular Carcinoma

B. Bartosch, 2010, Viruses.

Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolism.

B. Bartosch, 2009, Journal of hepatology.

Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play?

B. Bartosch, 2014, Gut.

T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against hepatitis C virus in non-human primates

B. Bartosch, F. Cosset, J. Heeney, 2016 .

Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5α proteins including human TRIM5α

B. Bartosch, Y. Takeuchi, T. Schaller, 2009, The Journal of general virology.

An Update on the Metabolic Landscape of Oncogenic Viruses

B. Bartosch, A. Gaballah, 2022, Cancers.

Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2

B. Bartosch, J. Dubuisson, F. Cosset, 2005, Journal of Virology.

2-Deoxyglucose, an Inhibitor of Glycolysis, Enhances the Oncolytic Effect of Coxsackievirus

B. Bartosch, P. Chumakov, S. Kochetkov, 2022, Cancers.

Plasma-Like Culture Medium for the Study of Viruses

B. Bartosch, O. Smirnova, O. Ivanova, 2022, mBio.

HCV Virology

F. Zoulim, B. Bartosch, E. Pécheur, 2021, Hepatitis C: Epidemiology, Prevention and Elimination.

C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles*

B. Bartosch, F. Cosset, R. Altmeyer, 2004, Journal of Biological Chemistry.

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets

F. Negro, S. Clément, B. Bartosch, 2016, Scientific Reports.

Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes

B. Bartosch, J. Dubuisson, F. Cosset, 2003, The Journal of experimental medicine.

Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins.

F. Penin, B. Bartosch, F. Cosset, 2005, The Journal of general virology.

Xenotransplantation and pig endogenous retroviruses

B. Bartosch, Y. Takeuchi, S. Magre, 2003, Reviews in medical virology.

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.

R. Dwek, F. Zoulim, P. Roingeard, 2007, The Journal of general virology.

Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection

J. Pawlotsky, D. Lavillette, P. Donot, 2005, Journal of Virology.

Activation of Polyamine Catabolism by N1,N11-Diethylnorspermine in Hepatic HepaRG Cells Induces Dedifferentiation and Mesenchymal-Like Phenotype

B. Bartosch, L. Alhonen, G. Krasnov, 2018, Cells.

Oxidative Stress during HIV Infection: Mechanisms and Consequences

B. Bartosch, S. Kochetkov, O. Ivanova, 2016, Oxidative medicine and cellular longevity.

Studying HCV cell entry with HCV pseudoparticles (HCVpp).

B. Bartosch, F. Cosset, 2009, Methods in molecular biology.

Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains

F. Zoulim, D. Lavillette, B. Bartosch, 2009, PLoS pathogens.

The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus*

S. Ricard-Blum, D. Lavillette, B. Bartosch, 2007, Journal of Biological Chemistry.

Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Glycoproteins

Birke Bartosch, Jean Dubuisson, B. Bartosch, 2005, Journal of Virology.

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

F. Penin, J. Pawlotsky, D. Lavillette, 2005, Journal of Virology.

Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor*

R. Cortese, A. Nicosia, B. Bartosch, 2003, Journal of Biological Chemistry.

Hepatitis C virus infection triggers a tumor‐like glutamine metabolism

M. Odenthal, F. Zoulim, B. Bartosch, 2017, Hepatology.

The mouse IAPE endogenous retrovirus can infect cells through any of the five GPI-anchored EphrinA proteins

B. Bartosch, F. Cosset, T. Heidmann, 2011, Retrovirology.

Metabolic reprogramming: a hallmark of viral oncogenesis

B. Bartosch, P. Lévy, 2016, Oncogene.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

D. Lavillette, A. Tarr, B. Bartosch, 2005, Journal of Virology.

Monoclonal Antibody AP 33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E 2 Envelope Glycoprotein

A. Tarr, B. Bartosch, F. Cosset, 2005 .

Strategies for retargeted gene delivery using vectors derived from lentiviruses.

B. Bartosch, F. Cosset, 2004, Current gene therapy.

Epstein - Barr Virus Transforming Protein LMP-1 Alters B Cells Gene Expression by Promoting Accumulation of the Oncoprotein ΔNp73α

B. Bartosch, M. Tommasino, J. McKay, 2013, PLoS pathogens.

Recent Advances in Hepatitis C Virus Cell Entry

B. Bartosch, J. Dubuisson, 2010, Viruses.

Cell entry of hepatitis C virus.

B. Bartosch, F. Cosset, 2006, Virology.

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.

R. Purcell, B. Bartosch, F. Cosset, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Redox Biology of Respiratory Viral Infections

B. Bartosch, S. Kochetkov, A. Ivanov, 2018, Viruses.

Characterization of Functional Hepatitis C Virus Envelope Glycoproteins

C. Voisset, B. Bartosch, J. Dubuisson, 2004, Journal of Virology.

Basic Residues in Hypervariable Region 1 of Hepatitis C Virus Envelope Glycoprotein E2 Contribute to Virus Entry

F. Penin, J. Pawlotsky, B. Bartosch, 2005, Journal of Virology.

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity

S. Emerson, R. Purcell, B. Bartosch, 2005, Hepatology.

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

S. Emerson, R. Purcell, J. Bukh, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Evidence and Consequence of Porcine Endogenous Retrovirus Recombination

Yasuhiro Takeuchi, Dimitrios Stefanidis, Richard Myers, 2004, Journal of Virology.

Synergistic effect of interleukin‐17 and tumour necrosis factor‐α on inflammatory response in hepatocytes through interleukin‐6‐dependent and independent pathways

B. Bartosch, P. Miossec, J. Molle, 2018, Clinical and experimental immunology.

Inflammasome-independent NLRP3 function enforces ATM activity in response to genotoxic stress

S. Lantuejoul, B. Bartosch, Y. Couté, 2023, Life Science Alliance.

NLRP3 controls ATM activation in response to DNA damage

S. Lantuejoul, B. Bartosch, Y. Couté, 2020, bioRxiv.

SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines

B. Bartosch, V. Mitkevich, V. Baklaushev, 2023, Cancers.

Plasma-Like Culture Medium for the Study of Viruses

B. Bartosch, O. Smirnova, O. Ivanova, 2022, mBio.

Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells

F. Zoulim, B. Bartosch, B. Jammart, 2013, Journal of Virology.

Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Integrity Is Required for Insulin Signaling and Is Implicated in Hepatic Insulin Resistance

F. Zoulim, B. Bartosch, H. Vidal, 2014, Diabetes.

PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B.

Yasuhiro Takeuchi, Birke Bartosch, B. Bartosch, 2002, The Journal of general virology.

Batch profiling calibration for robust NMR metabonomic data analysis

B. Bartosch, E. Jobard, B. Elena-Herrmann, 2013, Analytical and Bioanalytical Chemistry.

The long form of CDK2 arises via alternative splicing and forms an active protein kinase with cyclins A and E.

T. Hunt, B. Bartosch, R. Jaussi, 2001, DNA and cell biology.

Transcriptome Analysis of Redox Systems and Polyamine Metabolic Pathway in Hepatoma and Non-Tumor Hepatocyte-like Cells

B. Bartosch, G. Krasnov, A. Snezhkina, 2023, Biomolecules.

Role of seipin in lipid droplet morphology and hepatitis C virus life cycle.

F. Negro, S. Clément, B. Bartosch, 2013, The Journal of general virology.

Effect of endothelial cell heterogeneity on nanoparticle uptake.

B. Bartosch, I. Zuhorn, A. Salvati, 2020, International journal of pharmaceutics.

Two phase kinetics of the inflammatory response from hepatocyte-peripheral blood mononuclear cell interactions

B. Bartosch, P. Miossec, J. Molle, 2019, Scientific Reports.

Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes

M. Odenthal, F. Zoulim, B. Bartosch, 2022, JHEP reports : innovation in hepatology.

Hypoxia sensing by hepatic stellate cells leads to VEGF-dependent angiogenesis and may contribute to accelerated liver regeneration

D. de Zélicourt, R. Wenger, B. Bartosch, 2020, Scientific Reports.

Hepatitis Delta Virus Antigens Trigger Oxidative Stress, Activate Antioxidant Nrf2/ARE Pathway, and Induce Unfolded Protein Response

B. Bartosch, S. Kochetkov, O. Smirnova, 2023, Antioxidants.

An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium.

F. Zoulim, B. Bartosch, M. Marion, 2014, Biochemical and biophysical research communications.

The Ig Domain Protein CD9P-1 Down-regulates CD81 Ability to Support Plasmodium yoelii Infection*

B. Bartosch, C. Boucheix, S. Charrin, 2009, The Journal of Biological Chemistry.

Hepatitis C Virus RNA-Dependent RNA Polymerase Is Regulated by Cysteine S-Glutathionylation

B. Bartosch, M. Kukhanova, S. Kochetkov, 2019, Oxidative medicine and cellular longevity.

Emerging anti‐HDV drugs and HBV cure strategies with anti‐HDV activity

F. Zoulim, B. Bartosch, B. Testoni, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Redox Biology of Infection and Consequent Disease

B. Bartosch, A. Ivanov, M. Isaguliants, 2020, Oxidative medicine and cellular longevity.

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

B. Bartosch, F. Cosset, J. Heeney, 2016, Gene Therapy.